According to this latest study, the 2020 growth of Monoclonal Antibodies will have significant change from previous year. By the most conservative estimates of global Monoclonal Antibodies market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Monoclonal Antibodies market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Monoclonal Antibodies market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Cancer

Autoimmune Diseases

Infection

Hematological Diseases

Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Oncology

Autoimmune and inflammatory diseases

Respiratory diseases

Ophthalmology

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

AbbVie

Roche

Johnson & Johnson

Amgen

Merck

BMS

Eli Lilly

Formation Biologics

Genmab

GlaxoSmithKline

Human Genome Sciences

mmunogen

MedImmune

Novartis

Pfizer

Seattle Genetics

Stemcentrx

Synthon Biopharmaceuticals

Takeda

Teva

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Monoclonal Antibodies Consumption 2016-2026

2.1.2 Monoclonal Antibodies Consumption CAGR by Region

2.2 Monoclonal Antibodies Segment by Type

2.2.1 Cancer

2.2.2 Autoimmune Diseases

2.2.3 Infection

2.2.4 Hematological Diseases

2.2.5 Others

2.3 Monoclonal Antibodies Sales by Type

2.3.1 Global Monoclonal Antibodies Sales Market Share by Type (2016-2021)

2.3.2 Global Monoclonal Antibodies Revenue and Market Share by Type (2016-2021)

2.3.3 Global Monoclonal Antibodies Sale Price by Type (2016-2021)

2.4 Monoclonal Antibodies Segment by Application

2.4.1 Oncology

2.4.2 Autoimmune and inflammatory diseases

2.4.3 Respiratory diseases

2.4.4 Ophthalmology

2.5 Monoclonal Antibodies Sales by Application

2.5.1 Global Monoclonal Antibodies Sale Market Share by Application (2016-2021)

2.5.2 Global Monoclonal Antibodies Revenue and Market Share by Application (2016-2021)

2.5.3 Global Monoclonal Antibodies Sale Price by Application (2016-2021)

3 Global Monoclonal Antibodies by Company

3.1 Global Monoclonal Antibodies Sales Market Share by Company

3.1.1 Global Monoclonal Antibodies Sales by Company (2019-2021)

3.1.2 Global Monoclonal Antibodies Sales Market Share by Company (2019-2021)

3.2 Global Monoclonal Antibodies Revenue Market Share by Company

3.2.1 Global Monoclonal Antibodies Revenue by Company (2019-2021)

3.2.2 Global Monoclonal Antibodies Revenue Market Share by Company (2019-2021)

3.3 Global Monoclonal Antibodies Sale Price by Company

3.4 Global Manufacturers Monoclonal Antibodies Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Monoclonal Antibodies Product Location Distribution

3.4.2 Players Monoclonal Antibodies Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Monoclonal Antibodies by Region

4.1 Global Monoclonal Antibodies by Region

4.1.1 Global Monoclonal Antibodies Sales by Region

4.1.2 Global Monoclonal Antibodies Revenue by Region

4.2 Americas Monoclonal Antibodies Sales Growth

4.3 APAC Monoclonal Antibodies Sales Growth

4.4 Europe Monoclonal Antibodies Sales Growth

4.5 Middle East & Africa Monoclonal Antibodies Sales Growth

5 Americas

5.1 Americas Monoclonal Antibodies Sales by Country

5.1.1 Americas Monoclonal Antibodies Sales by Country (2016-2021)

5.1.2 Americas Monoclonal Antibodies Revenue by Country (2016-2021)

5.2 Americas Monoclonal Antibodies Sales by Type

5.3 Americas Monoclonal Antibodies Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Monoclonal Antibodies Sales by Region

6.1.1 APAC Monoclonal Antibodies Sales by Region (2016-2021)

6.1.2 APAC Monoclonal Antibodies Revenue by Region (2016-2021)

6.2 APAC Monoclonal Antibodies Sales by Type

6.3 APAC Monoclonal Antibodies Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Monoclonal Antibodies by Country

7.1.1 Europe Monoclonal Antibodies Sales by Country (2016-2021)

7.1.2 Europe Monoclonal Antibodies Revenue by Country (2016-2021)

7.2 Europe Monoclonal Antibodies Sales by Type

7.3 Europe Monoclonal Antibodies Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Monoclonal Antibodies by Country

8.1.1 Middle East & Africa Monoclonal Antibodies Sales by Country (2016-2021)

8.1.2 Middle East & Africa Monoclonal Antibodies Revenue by Country (2016-2021)

8.2 Middle East & Africa Monoclonal Antibodies Sales by Type

8.3 Middle East & Africa Monoclonal Antibodies Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Monoclonal Antibodies Distributors

10.3 Monoclonal Antibodies Customer

11 Global Monoclonal Antibodies Market Forecast

11.1 Global Monoclonal Antibodies Forecast by Region

11.1.1 Global Monoclonal Antibodies Forecast by Regions (2021-2026)

11.2.2 Global Monoclonal Antibodies Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Countries

11.3 APAC Forecast by Region

11.4 Europe Forecast by Countries

11.5 Middle East & Africa Forecast by Countries

11.6 Global Monoclonal Antibodies Forecast by Type

11.7 Global Monoclonal Antibodies Forecast by Application

12 Key Players Analysis

12.1 AbbVie

12.1.1 AbbVie AbbVie Company Information

12.1.2 AbbVie Monoclonal Antibodies Product Offered

12.1.3 AbbVie Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 AbbVie Main Business Overview

12.1.5 AbbVie Latest Developments

12.2 Roche

12.2.1 Roche Company Information

12.2.2 Roche Monoclonal Antibodies Product Offered

12.2.3 Roche Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Roche Main Business Overview

12.2.5 Roche Latest Developments

12.3 Johnson & Johnson

12.3.1 Johnson & Johnson Company Information

12.3.2 Johnson & Johnson Monoclonal Antibodies Product Offered

12.3.3 Johnson & Johnson Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Johnson & Johnson Main Business Overview

12.3.5 Johnson & Johnson Latest Developments

12.4 Amgen

12.4.1 Amgen Company Information

12.4.2 Amgen Monoclonal Antibodies Product Offered

12.4.3 Amgen Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Amgen Main Business Overview

12.4.5 Amgen Latest Developments

12.5 Merck

12.5.1 Merck Company Information

12.5.2 Merck Monoclonal Antibodies Product Offered

12.5.3 Merck Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Merck Main Business Overview

12.5.5 Merck Latest Developments

12.6 BMS

12.6.1 BMS Company Information

12.6.2 BMS Monoclonal Antibodies Product Offered

12.6.3 BMS Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 BMS Main Business Overview

12.6.5 BMS Latest Developments

12.7 Eli Lilly

12.7.1 Eli Lilly Company Information

12.7.2 Eli Lilly Monoclonal Antibodies Product Offered

12.7.3 Eli Lilly Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Eli Lilly Main Business Overview

12.7.5 Eli Lilly Latest Developments

12.8 Formation Biologics

12.8.1 Formation Biologics Company Information

12.8.2 Formation Biologics Monoclonal Antibodies Product Offered

12.8.3 Formation Biologics Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Formation Biologics Main Business Overview

12.8.5 Formation Biologics Latest Developments

12.9 Genmab

12.9.1 Genmab Company Information

12.9.2 Genmab Monoclonal Antibodies Product Offered

12.9.3 Genmab Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Genmab Main Business Overview

12.9.5 Genmab Latest Developments

12.10 GlaxoSmithKline

12.10.1 GlaxoSmithKline Company Information

12.10.2 GlaxoSmithKline Monoclonal Antibodies Product Offered

12.10.3 GlaxoSmithKline Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 GlaxoSmithKline Main Business Overview

12.10.5 GlaxoSmithKline Latest Developments

12.11 Human Genome Sciences

12.11.1 Human Genome Sciences Company Information

12.11.2 Human Genome Sciences Monoclonal Antibodies Product Offered

12.11.3 Human Genome Sciences Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Human Genome Sciences Main Business Overview

12.11.5 Human Genome Sciences Latest Developments

12.12 mmunogen

12.12.1 mmunogen Company Information

12.12.2 mmunogen Monoclonal Antibodies Product Offered

12.12.3 mmunogen Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 mmunogen Main Business Overview

12.12.5 mmunogen Latest Developments

12.13 MedImmune

12.13.1 MedImmune Company Information

12.13.2 MedImmune Monoclonal Antibodies Product Offered

12.13.3 MedImmune Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 MedImmune Main Business Overview

12.13.5 MedImmune Latest Developments

12.14 Novartis

12.14.1 Novartis Company Information

12.14.2 Novartis Monoclonal Antibodies Product Offered

12.14.3 Novartis Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)

12.14.4 Novartis Main Business Overview

12.14.5 Novartis Latest Developments

12.15 Pfizer

12.15.1 Pfizer Company Information

12.15.2 Pfizer Monoclonal Antibodies Product Offered

12.15.3 Pfizer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)

12.15.4 Pfizer Main Business Overview

12.15.5 Pfizer Latest Developments

12.16 Seattle Genetics

12.16.1 Seattle Genetics Company Information

12.16.2 Seattle Genetics Monoclonal Antibodies Product Offered

12.16.3 Seattle Genetics Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)

12.16.4 Seattle Genetics Main Business Overview

12.16.5 Seattle Genetics Latest Developments

12.17 Stemcentrx

12.17.1 Stemcentrx Company Information

12.17.2 Stemcentrx Monoclonal Antibodies Product Offered

12.17.3 Stemcentrx Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)

12.17.4 Stemcentrx Main Business Overview

12.17.5 Stemcentrx Latest Developments

12.18 Synthon Biopharmaceuticals

12.18.1 Synthon Biopharmaceuticals Company Information

12.18.2 Synthon Biopharmaceuticals Monoclonal Antibodies Product Offered

12.18.3 Synthon Biopharmaceuticals Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)

12.18.4 Synthon Biopharmaceuticals Main Business Overview

12.18.5 Synthon Biopharmaceuticals Latest Developments

12.19 Takeda

12.19.1 Takeda Company Information

12.19.2 Takeda Monoclonal Antibodies Product Offered

12.19.3 Takeda Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)

12.19.4 Takeda Main Business Overview

12.19.5 Takeda Latest Developments

12.20 Teva

12.20.1 Teva Company Information

12.20.2 Teva Monoclonal Antibodies Product Offered

12.20.3 Teva Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)

12.20.4 Teva Main Business Overview

12.20.5 Teva Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Monoclonal Antibodies Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Cancer

Table 3. Major Players of Autoimmune Diseases

Table 4. Major Players of Infection

Table 5. Major Players of Hematological Diseases

Table 6. Major Players of Others

Table 7. Global Monoclonal Antibodies Sales by Type (2016-2021) & (Kg)

Table 8. Global Monoclonal Antibodies Sales Market Share by Type (2016-2021)

Table 9. Global Monoclonal Antibodies Revenue by Type (2016-2021) & ($ million)

Table 10. Global Monoclonal Antibodies Revenue Market Share by Type (2016-2021)

Table 11. Global Monoclonal Antibodies Sale Price by Type (2016-2021)

Table 12. Global Monoclonal Antibodies Sales by Application (2016-2021) & (Kg)

Table 13. Global Monoclonal Antibodies Sales Market Share by Application (2016-2021)

Table 14. Global Monoclonal Antibodies Value by Application (2016-2021)

Table 15. Global Monoclonal Antibodies Revenue Market Share by Application (2016-2021)

Table 16. Global Monoclonal Antibodies Sale Price by Application (2016-2021)

Table 17. Global Monoclonal Antibodies Sales by Company (2019-2021) & (Kg)

Table 18. Global Monoclonal Antibodies Sales Market Share by Company (2019-2021)

Table 19. Global Monoclonal Antibodies Revenue by Company (2019-2021) ($ Millions)

Table 20. Global Monoclonal Antibodies Revenue Market Share by Company (2019-2021)

Table 21. Global Monoclonal Antibodies Sale Price by Company (2019-2021)

Table 22. Key Manufacturers Monoclonal Antibodies Producing Area Distribution and Sales Area

Table 23. Players Monoclonal Antibodies Products Offered

Table 24. Monoclonal Antibodies Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Monoclonal Antibodies Sales by Region (2016-2021) (Kg)

Table 28. Global Monoclonal Antibodies Sales Market Share by Region (2016-2021)

Table 29. Global Monoclonal Antibodies Revenue by Region (2016-2021) & ($ Millions)

Table 30. Global Monoclonal Antibodies Revenue Market Share by Region (2016-2021)

Table 31. Americas Monoclonal Antibodies Sales by Country (2016-2021) & (Kg)

Table 32. Americas Monoclonal Antibodies Sales Market Share by Country (2016-2021)

Table 33. Americas Monoclonal Antibodies Revenue by Country (2016-2021) & ($ Millions)

Table 34. Americas Monoclonal Antibodies Revenue Market Share by Country (2016-2021)

Table 35. Americas Monoclonal Antibodies Sales by Type (2016-2021) & (Kg)

Table 36. Americas Monoclonal Antibodies Sales Market Share by Type (2016-2021)

Table 37. Americas Monoclonal Antibodies Sales by Application (2016-2021) & (Kg)

Table 38. Americas Monoclonal Antibodies Sales Market Share by Application (2016-2021)

Table 39. APAC Monoclonal Antibodies Sales by Region (2016-2021) & (Kg)

Table 40. APAC Monoclonal Antibodies Sales Market Share by Region (2016-2021)

Table 41. APAC Monoclonal Antibodies Revenue by Region (2016-2021) & ($ Millions)

Table 42. APAC Monoclonal Antibodies Revenue Market Share by Region (2016-2021)

Table 43. APAC Monoclonal Antibodies Sales by Type (2016-2021) & (Kg)

Table 44. APAC Monoclonal Antibodies Sales Market Share by Type (2016-2021)

Table 45. APAC Monoclonal Antibodies Sales by Application (2016-2021) & (Kg)

Table 46. APAC Monoclonal Antibodies Sales Market Share by Application (2016-2021)

Table 47. Europe Monoclonal Antibodies Sales by Country (2016-2021) & (Kg)

Table 48. Europe Monoclonal Antibodies Sales Market Share by Country (2016-2021)

Table 49. Europe Monoclonal Antibodies Revenue by Country (2016-2021) & ($ Millions)

Table 50. Europe Monoclonal Antibodies Revenue Market Share by Country (2016-2021)

Table 51. Europe Monoclonal Antibodies Sales by Type (2016-2021) & (Kg)

Table 52. Europe Monoclonal Antibodies Sales Market Share by Type (2016-2021)

Table 53. Europe Monoclonal Antibodies Sales by Application (2016-2021) & (Kg)

Table 54. Europe Monoclonal Antibodies Sales Market Share by Application (2016-2021)

Table 55. Middle East & Africa Monoclonal Antibodies Sales by Country (2016-2021) & (Kg)

Table 56. Middle East & Africa Monoclonal Antibodies Sales Market Share by Country (2016-2021)

Table 57. Middle East & Africa Monoclonal Antibodies Revenue by Country (2016-2021) & ($ Millions)

Table 58. Middle East & Africa Monoclonal Antibodies Revenue Market Share by Country (2016-2021)

Table 59. Middle East & Africa Monoclonal Antibodies Sales by Type (2016-2021) & (Kg)

Table 60. Middle East & Africa Monoclonal Antibodies Sales Market Share by Type (2016-2021)

Table 61. Middle East & Africa Monoclonal Antibodies Sales by Application (2016-2021) & (Kg)

Table 62. Middle East & Africa Monoclonal Antibodies Sales Market Share by Application (2016-2021)

Table 63. Global Monoclonal Antibodies Sales Forecast by Type (2021-2026) & (Kg)

Table 64. Global Monoclonal Antibodies Sales Market Share Forecast by Type (2021-2026)

Table 65. Global Monoclonal Antibodies Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 66. Global Monoclonal Antibodies Revenue Market Share Forecast by Type (2021-2026)

Table 67. Global Monoclonal Antibodies Sales Forecast by Application (2021-2026) & (Kg)

Table 68. Global Monoclonal Antibodies Sales Market Share Forecast by Application (2021-2026)

Table 69. Global Monoclonal Antibodies Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 70. Global Monoclonal Antibodies Revenue Market Share Forecast by Application (2021-2026)

Table 71. AbbVie Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 72. AbbVie Monoclonal Antibodies Product Offered

Table 73. AbbVie Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)

Table 74. AbbVie Main Business

Table 75. AbbVie Latest Developments

Table 76. Roche Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 77. Roche Monoclonal Antibodies Product Offered

Table 78. Roche Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)

Table 79. Roche Main Business

Table 80. Roche Latest Developments

Table 81. Johnson & Johnson Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 82. Johnson & Johnson Monoclonal Antibodies Product Offered

Table 83. Johnson & Johnson Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)

Table 84. Johnson & Johnson Main Business

Table 85. Johnson & Johnson Latest Developments

Table 86. Amgen Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 87. Amgen Monoclonal Antibodies Product Offered

Table 88. Amgen Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)

Table 89. Amgen Main Business

Table 90. Amgen Latest Developments

Table 91. Merck Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 92. Merck Monoclonal Antibodies Product Offered

Table 93. Merck Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)

Table 94. Merck Main Business

Table 95. Merck Latest Developments

Table 96. BMS Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 97. BMS Monoclonal Antibodies Product Offered

Table 98. BMS Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)

Table 99. BMS Main Business

Table 100. BMS Latest Developments

Table 101. Eli Lilly Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 102. Eli Lilly Monoclonal Antibodies Product Offered

Table 103. Eli Lilly Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)

Table 104. Eli Lilly Main Business

Table 105. Eli Lilly Latest Developments

Table 106. Formation Biologics Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 107. Formation Biologics Monoclonal Antibodies Product Offered

Table 108. Formation Biologics Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)

Table 109. Formation Biologics Main Business

Table 110. Formation Biologics Latest Developments

Table 111. Genmab Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 112. Genmab Monoclonal Antibodies Product Offered

Table 113. Genmab Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)

Table 114. Genmab Main Business

Table 115. Genmab Latest Developments

Table 116. GlaxoSmithKline Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 117. GlaxoSmithKline Monoclonal Antibodies Product Offered

Table 118. GlaxoSmithKline Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)

Table 119. GlaxoSmithKline Main Business

Table 120. GlaxoSmithKline Latest Developments

Table 121. Human Genome Sciences Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 122. Human Genome Sciences Monoclonal Antibodies Product Offered

Table 123. Human Genome Sciences Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)

Table 124. Human Genome Sciences Main Business

Table 125. Human Genome Sciences Latest Developments

Table 126. mmunogen Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 127. mmunogen Monoclonal Antibodies Product Offered

Table 128. mmunogen Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)

Table 129. mmunogen Main Business

Table 130. mmunogen Latest Developments

Table 131. MedImmune Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 132. MedImmune Monoclonal Antibodies Product Offered

Table 133. MedImmune Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)

Table 134. MedImmune Main Business

Table 135. MedImmune Latest Developments

Table 136. Novartis Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 137. Novartis Monoclonal Antibodies Product Offered

Table 138. Novartis Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)

Table 139. Novartis Main Business

Table 140. Novartis Latest Developments

Table 141. Pfizer Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 142. Pfizer Monoclonal Antibodies Product Offered

Table 143. Pfizer Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)

Table 144. Pfizer Main Business

Table 145. Pfizer Latest Developments

Table 146. Seattle Genetics Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 147. Seattle Genetics Monoclonal Antibodies Product Offered

Table 148. Seattle Genetics Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)

Table 149. Seattle Genetics Main Business

Table 150. Seattle Genetics Latest Developments

Table 151. Stemcentrx Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 152. Stemcentrx Monoclonal Antibodies Product Offered

Table 153. Stemcentrx Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)

Table 154. Stemcentrx Main Business

Table 155. Stemcentrx Latest Developments

Table 156. Synthon Biopharmaceuticals Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 157. Synthon Biopharmaceuticals Monoclonal Antibodies Product Offered

Table 158. Synthon Biopharmaceuticals Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)

Table 159. Synthon Biopharmaceuticals Main Business

Table 160. Synthon Biopharmaceuticals Latest Developments

Table 161. Takeda Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 162. Takeda Monoclonal Antibodies Product Offered

Table 163. Takeda Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)

Table 164. Takeda Main Business

Table 165. Takeda Latest Developments

Table 166. Teva Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors

Table 167. Teva Monoclonal Antibodies Product Offered

Table 168. Teva Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)

Table 169. Teva Main Business

Table 170. Teva Latest Developments

List of Figures

Figure 1. Picture of Monoclonal Antibodies

Figure 2. Monoclonal Antibodies Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Monoclonal Antibodies Sales Growth Rate 2016-2026 (Kg)

Figure 7. Global Monoclonal Antibodies Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Monoclonal Antibodies Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Cancer

Figure 10. Product Picture of Autoimmune Diseases

Figure 11. Product Picture of Infection

Figure 12. Product Picture of Hematological Diseases

Figure 13. Product Picture of Others

Figure 14. Global Monoclonal Antibodies Sales Market Share by Type in 2020

Figure 15. Global Monoclonal Antibodies Revenue Market Share by Type (2016-2021)

Figure 16. Monoclonal Antibodies Consumed in Oncology

Figure 17. Global Monoclonal Antibodies Market: Oncology (2016-2021) & (Kg)

Figure 18. Monoclonal Antibodies Consumed in Autoimmune and inflammatory diseases

Figure 19. Global Monoclonal Antibodies Market: Autoimmune and inflammatory diseases (2016-2021) & (Kg)

Figure 20. Monoclonal Antibodies Consumed in Respiratory diseases

Figure 21. Global Monoclonal Antibodies Market: Respiratory diseases (2016-2021) & (Kg)

Figure 22. Monoclonal Antibodies Consumed in Ophthalmology

Figure 23. Global Monoclonal Antibodies Market: Ophthalmology (2016-2021) & (Kg)

Figure 24. Global Monoclonal Antibodies Sales Market Share by Application (2016-2021)

Figure 25. Global Monoclonal Antibodies Revenue Market Share by Application in 2020

Figure 26. Global Monoclonal Antibodies Revenue Market by Company in 2020 ($ Million)

Figure 27. Global Monoclonal Antibodies Revenue Market Share by Company in 2020

Figure 28. Global Monoclonal Antibodies Sales Market Share by Regions (2016-2021)

Figure 29. Global Monoclonal Antibodies Revenue Market Share by Region in 2020

Figure 30. Americas Monoclonal Antibodies Sales 2016-2021 (Kg)

Figure 31. Americas Monoclonal Antibodies Revenue 2016-2021 ($ Millions)

Figure 32. APAC Monoclonal Antibodies Sales 2016-2021 (Kg)

Figure 33. APAC Monoclonal Antibodies Revenue 2016-2021 ($ Millions)

Figure 34. Europe Monoclonal Antibodies Sales 2016-2021 (Kg)

Figure 35. Europe Monoclonal Antibodies Revenue 2016-2021 ($ Millions)

Figure 36. Middle East & Africa Monoclonal Antibodies Sales 2016-2021 (Kg)

Figure 37. Middle East & Africa Monoclonal Antibodies Revenue 2016-2021 ($ Millions)

Figure 38. Americas Monoclonal Antibodies Sales Market Share by Country in 2020

Figure 39. Americas Monoclonal Antibodies Revenue Market Share by Country in 2020

Figure 40. Americas Monoclonal Antibodies Sales Market Share by Type in 2020

Figure 41. Americas Monoclonal Antibodies Sales Market Share by Application in 2020

Figure 42. United States Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)

Figure 43. Canada Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)

Figure 44. Mexico Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)

Figure 45. Brazil Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)

Figure 46. APAC Monoclonal Antibodies Sales Market Share by Region in 2020

Figure 47. APAC Monoclonal Antibodies Revenue Market Share by Regions in 2020

Figure 48. APAC Monoclonal Antibodies Sales Market Share by Type in 2020

Figure 49. APAC Monoclonal Antibodies Sales Market Share by Application in 2020

Figure 50. China Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)

Figure 51. Japan Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)

Figure 52. Korea Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)

Figure 53. Southeast Asia Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)

Figure 54. India Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)

Figure 55. Australia Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)

Figure 56. Europe Monoclonal Antibodies Sales Market Share by Country in 2020

Figure 57. Europe Monoclonal Antibodies Revenue Market Share by Country in 2020

Figure 58. Europe Monoclonal Antibodies Sales Market Share by Type in 2020

Figure 59. Europe Monoclonal Antibodies Sales Market Share by Application in 2020

Figure 60. Germany Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)

Figure 61. France Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)

Figure 62. UK Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)

Figure 63. Italy Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)

Figure 64. Russia Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)

Figure 65. Middle East & Africa Monoclonal Antibodies Sales Market Share by Country in 2020

Figure 66. Middle East & Africa Monoclonal Antibodies Revenue Market Share by Country in 2020

Figure 67. Middle East & Africa Monoclonal Antibodies Sales Market Share by Type in 2020

Figure 68. Middle East & Africa Monoclonal Antibodies Sales Market Share by Application in 2020

Figure 69. Egypt Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)

Figure 70. South Africa Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)

Figure 71. Israel Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)

Figure 72. Turkey Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)

Figure 73. GCC Country Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)

Figure 74. Channels of Distribution

Figure 75. Distributors Profiles